NervGen Pharma Corp.
NervGen Pharma Corp. (NGEN.V) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
ngen.v · stock forecast · 1 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 1 Wall Street analysts in the past 3 months
Buy
1 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $5.15
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $4.93 | ↓ 4.34% |
1-day model range: $4.89–$4.96. Peak: $4.96 (-4.34%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -12.3% |
| 2028 | $4 | -18.2% |
| 2029 | $4 | -21.3% |
| 2030 | $4 | -22.9% |
| 2031 | — | -23.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · NGEN.V · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2021-07-13 | Industrial Alliance | Maintains | Speculative Buy→Buy |
Wall Street analysts have recently issued updated ratings on NervGen Pharma Corp. (NGEN.V) stock. Of the recent 1 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover NGEN.V.
Analyst Recommendation Trends
NGEN.V analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
Revenue Next Year
$0M
EPS This Year
$-0.30
EPS Next Year
$-0.39
↑ 31.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast NGEN.V EPS of $-0.30 for the current fiscal year, based on estimates from 3 analysts. The NGEN.V revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The NGEN.V stock forecast is supported by two independent data sources: analyst consensus ratings from 1 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NGEN.V price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.
The NGEN.V short-term stock prediction for tomorrow is $4.93 (-4.34%). The NGEN.V stock price prediction for 2027 estimates an average of $5. The NGEN.V stock prediction for 2030 projects a range of $4–$4.
NervGen Pharma Corp. trades on TSXV under the ticker NGEN.V. The NGEN.V stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
NGEN.V forecast · 8 questionsAccording to 1 Wall Street analysts, the average 12-month NGEN.V price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $5.15.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.